Always putting healthier
lives first
scroll
News
-
Sawai Announces Listing of Two Generic Drugs with Three Strengths
-
Sawai Receives Approvals for Three Generic Drugs with Four Strengths
-
Notice of Transfer (Sale of Shares/Equity Interests) of Sawai’s U.S. Subsidiary / Sub-subsidiary
-
Sawai Announces Listing of a single Generic Drug with Two Strengths
-
Launch of Pitavastatin tablets in the United States – Sawai’s First generic ANDA approval and launch for US market under Paragraph IV–
![Company Information](/assets/images/top/top-company_bg.jpg)
Company Information
Group Companies
![Investor Relations](/assets/images/top/top-ir_bg.jpg)